↓ Skip to main content

Inflamação e má resposta ao uso de eritropoetina na doença renal crônica

Overview of attention for article published in Jornal Brasileiro de Nefrologia, January 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inflamação e má resposta ao uso de eritropoetina na doença renal crônica
Published in
Jornal Brasileiro de Nefrologia, January 2015
DOI 10.5935/0101-2800.20150039
Pubmed ID
Authors

Wander Valadares de Oliveira, Adriano de Paula Sabino, Roberta Carvalho Figueiredo, Danyelle Romana Alves Rios

Abstract

The prevalence of kidney chronic disease (CKD) has increased in recent years and several risk factors have been associated with the onset and progression of CDK, such as obesity, hypertension and diabetes mellitus. In addition, anemia is one of the complications of CRD, mainly by iron and erythropoietin (EPO) deficiency and the management of this situation is with exogenous erythropoietin, but patients undergoing dialysis present chronic inflammatory process followed by EPO resistance and anemia, malnutrition, worse of atherosclerosis and increased mortality ratio. The aim of this study was to review the association of erythropoietin resistance and chronic inflammatory process in patients with chronic renal disease.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 106 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 18%
Student > Bachelor 17 16%
Student > Postgraduate 11 10%
Researcher 7 7%
Professor > Associate Professor 6 6%
Other 22 21%
Unknown 24 23%
Readers by discipline Count As %
Medicine and Dentistry 38 36%
Nursing and Health Professions 10 9%
Biochemistry, Genetics and Molecular Biology 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Agricultural and Biological Sciences 5 5%
Other 11 10%
Unknown 27 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 December 2015.
All research outputs
#22,778,604
of 25,394,764 outputs
Outputs from Jornal Brasileiro de Nefrologia
#308
of 366 outputs
Outputs of similar age
#306,696
of 359,691 outputs
Outputs of similar age from Jornal Brasileiro de Nefrologia
#18
of 26 outputs
Altmetric has tracked 25,394,764 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 366 research outputs from this source. They receive a mean Attention Score of 2.5. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,691 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.